Brief: Titan Pharma Completes Debt Settlement With Molteni And Horizon
02/11/2020 13:15
Nov 2 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS COMPLETES DEBT SETTLEMENT WITH
MOLTENI AND
HORIZON & ACQUISITON OF JT PHARMA'S KAPPA OPIOID AGONIST
PEPTIDE, JT-09
* TITAN - DUE TO DEBT SETTLEMENT WITH MOLTENI & HORIZON, NO
LIENS
REMAINING ON CO'S ASSETS, INCLUDING ALL PRONEURA INTELLECTUAL
PROPERTY
Source text for Eikon: ID:nPntXFpja
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.